Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of the Pain Relieving Effect of Dronabinol in Central Neuropathic Pain Related to Multiple Sclerosis
This study has been completed.
Study NCT00959218   Information provided by Bionorica Research GmbH

First Received on August 13, 2009.   Last Updated on February 2, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Multiple Sclerosis
Neuralgia
Sclerosis
More general conditions related to this trial
Autoimmune Diseases
Autoimmune Diseases of the Nervous System
Demyelinating Autoimmune Diseases, CNS
Demyelinating Diseases
Immune System Diseases
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Diseases
Pain
Pathologic Processes
Peripheral Nervous System Diseases
Signs and Symptoms
Interventions listed in this trial
Dronabinol
Placebo
Additional drug interventions recognized in this trial
Tetrahydrocannabinol
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Central Nervous System Agents
Hallucinogens
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Bionorica Research GmbH


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services